Literature DB >> 2138845

Relationship between regional myocardial blood flow and the distribution of 99mTc-sestamibi in the presence of total coronary artery occlusion.

S A Mousa1, J M Cooney, S J Williams.   

Abstract

This study was designed to assess the relationship between the distribution of the monocationic 99mTc-hexakis-2-methoxy, 2-methylpropylisonitrile (99mTc-sestamibi) and regional myocardial blood flow (RMBF) in swine. The left anterior descending coronary artery (LAD) was totally occluded and dipyridamole (0.4 mg/kg) was intravenously infused over 4 minutes. 99mTc-sestamibi and 201Tl were coinjected intravenously and a set of microspheres (15 microns) labelled with 113Sn or 55Nb was injected via a left atrial cannula. Animals were put to death at different times after injection of 99mTc-sestamibi/201Tl and the left ventricle was sectioned for gamma spectroscopy. Regression analysis of regional myocardial distribution of 99mTc-sestamibi or 201Tl versus microsphere-determined RMBF demonstrated a linear relationship with flow up to 2.5 ml/min/gm. The myocardial uptake for both 99mTc-sestamibi and 201Tl at higher flow levels was shown not to follow a linear relationship to microsphere-determined RMBF. The first-pass myocardial extraction fractions (%EF) of 99mTc-sestamibi and 201Tl in dogs were 65.5 +/- 2.5% and 82 +/- 3%, respectively (p less than 0.001), at resting flow. At flow levels above the resting flow, a significant decrease in the first-pass extraction fraction for both tracers was shown. At hyperemic flow levels (two to three times the resting flow), the %EF for both tracers are not significantly different. These data provide a basic validation for the utility of 99mTc-sestamibi as a reliable myocardial perfusion imaging agent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138845     DOI: 10.1016/s0002-8703(05)80321-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

1.  Effect of coronary reperfusion on technetium-99m methoxyisobutylisonitrile uptake by viable and necrotic myocardium in the dog.

Authors:  Y Merhi; J G Latour; A Arsenault; G Rousseau
Journal:  Eur J Nucl Med       Date:  1992

2.  Organ biodistribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses.

Authors:  Kengo Hatada; Mirta Ruiz; Laurent M Riou; Ronaldo L Lima; Allen R Goode; Denny D Watson; George A Beller; David K Glover
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

3.  The birth of a new radiopharmaceutical. Industrial perspective: from IND to NDA.

Authors:  L P Giering; J E Smith
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

4.  Quantitative comparison of single-isotope and dual-isotope stress-rest single-photon emission computed tomographic imaging for reversibility of defects.

Authors:  H M Siebelink; D Natale; A J Sinusas; F J Wackers
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

5.  Comparative evaluation of the diagnostic accuracy of (99m)Tc-sestamibi gated SPECT using five different sets of image acquisitions at stress and rest phases for the diagnosis of coronary artery disease.

Authors:  Babak Fallahi; Mahdi Haghighatafshar; Farinaz Farhoudi; Yalda Salehi; Farahnaz Aghahosseini
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-12-15

6.  Myocardial technetium 99m-labeled sestamibi single-photon emission computed tomographic imaging in the detection of coronary artery disease: comparison between early (15 minutes) and delayed (60 minutes) imaging.

Authors:  R Taillefer; R Lambert; G Bisson; C Benjamin; D C Phaneuf
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

7.  Time course of technetium-99m sestamibi myocardial distribution in dogs with a permanent or transient coronary occlusion.

Authors:  Y Merhi; A Arsenault; J G Latour
Journal:  Eur J Nucl Med       Date:  1994-06

Review 8.  Technetium-labeled myocardial imaging agents.

Authors:  A S Iskandrian; J Heo
Journal:  Int J Card Imaging       Date:  1992

9.  Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention.

Authors:  P Crane; R Laliberté; S Heminway; M Thoolen; C Orlandi
Journal:  Eur J Nucl Med       Date:  1993-01

Review 10.  Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR.

Authors:  Aiden Abidov; Vasken Dilsizian; Rami Doukky; W Lane Duvall; Christopher Dyke; Michael D Elliott; Fadi G Hage; Milena J Henzlova; Nils P Johnson; Ronald G Schwartz; Gregory S Thomas; Andrew J Einstein
Journal:  J Cardiovasc Magn Reson       Date:  2018-12-20       Impact factor: 5.364

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.